Majida, 58, a Syrian patient at MSF’s non-communicable diseases (NCDs) project in Irbid governorate, northern Jordan, close to the Syrian borders, has her blood pressure ochecked by an MSF nurse in one of the two NCDs clinics in Irbid Photograph by Maya Abu Ata
Statement |

MSF statement on EB154/7 - Follow up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases (NCDs)

1 min
DIABETES
Photograph by Maya Abu Ata
Majida, 58, a Syrian patient at MSF’s non-communicable diseases (NCDs) project in Irbid governorate, northern Jordan, close to the Syrian borders, has her blood pressure ochecked by an MSF nurse in one of the two NCDs clinics in Irbid Photograph by Maya Abu Ata

Access to essential medicines and diagnostics for people with NCDs is severely lacking, including in emergency and humanitarian settings.

WHO Executive Board's Special Session on Ebola UN Photo/Christopher Black

Read all MSF statements at WHO Executive Board 154th session

Médecins Sans Frontières calls on WHO to:   

  • Urgently issue clinical guidance for public health programmes on the management of people with type 1 and 2 diabetes, including the use of newer medicines for diabetes mostly available in high-income settings only; 
  • Support member states in developing harmonised national and regional guidance following WHO 2021 hypertension guidelines;  
  • Develop programmatic guidance to support the integration of diabetes and hypertension care into primary care, including the principle of differentiated service delivery that has successfully enabled scale up of HIV care; 
  • Ensure price transparency for all diabetes medicines in the Model List of Essential Medicines, including insulin in all formulations, as outlined in the diabetes resolution; and  
  • Support member states in pooled procurement of NCD medicines with fair prices based on cost of production data. 

Read, watch, share